Northern Trust’s Asterias Biotherapeutics Warrants AST.WS Stock Holding History
Bought
Maintained
Sold
Northern Trust's AST.WS Position: Q3 2017 in Review
Northern Trust sold out of Asterias Biotherapeutics Warrants (AST.WS) in Q3 2017, closing a stake of 17,548 shares — an estimated $9K sold.
Northern Trust first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $10K in Q4 2016. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.
- Northern Trust reported no remaining Asterias Biotherapeutics Warrants position as of Q3 2017 after selling out during the quarter.
- Northern Trust sold 17,548 Asterias Biotherapeutics Warrants shares in Q3 2017, an estimated $9K.
- Northern Trust first reported a position in Asterias Biotherapeutics Warrants in Q2 2016 and held it in 5 quarters.
- Northern Trust's Asterias Biotherapeutics Warrants position peaked at $10K in Q4 2016.
- 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Warrants as of Q3 2017.
Based on Northern Trust's 13F filing for Q3 2017, filed 13 Nov 2017.